Literature DB >> 6498429

The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic.

R L Ryall, J N Darroch, V R Marshall.   

Abstract

The daily urinary excretion of calcium, oxalate, glycosaminoglycans and uric acid, and the 24-h urinary pH and volume were measured in 61 normal men and in 81 men with a history of renal stone disease. The following features of these data were noted: No significant difference could be demonstrated between the stone-formers and normals with respect to any of the variables measured. The values of each of the urinary parameters were positively and significantly correlated with those of at least two other parameters in one or both subject groups. The probability density histograms constructed from the data for each urinary variable in each subject group were unsuitable as the basis for calculation of individual relative risk factors. Thus it was concluded that the data were inappropriate for the calculation of "overall relative probability of forming stones" (P'SF) and that such an index is unlikely to be of use in the assessment and management of stone-formers attending a general hospital out-patient clinic.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498429     DOI: 10.1111/j.1464-410x.1984.tb05345.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

Review 1.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  Risk formulas in calcium oxalate urolithiasis.

Authors:  H G Tiselius
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 3.  Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

Authors:  R L Ryall
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

4.  Weekend versus weekday urine collections in assessment of stone-formers.

Authors:  R W Norman
Journal:  J R Soc Med       Date:  1996-10       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.